妈咪爱联合思密达治疗母乳性黄疸疗效观察  

Observation of the clinical effects of Mami′ai combined with smecta in the treatment of breast milk jaundice

作　　者：刘国群[1] 朱波[1] 

机构地区：[1]四川省崇州市妇幼保健院,四川崇州611230

出　　处：《四川生理科学杂志》2011年第4期163-165,共3页Sichuan Journal of Physiological Sciences

摘　　要：目的:观察妈咪爱联合思密达对降低母乳性黄疸患儿的血清胆红素的作用以及疗程的影响。方法:将198例母乳性黄疸患儿随机分为对照组和治疗组两组。对照组给以常规治疗,治疗组在常规治疗的基础上加用妈咪爱和思密达口服。结果:治疗组治疗后血清胆红素为69.04±11.17μmol.L-1,对照组为92.10±14.76μmol.L-1,两组相比有显著性差异(P<0.01)。显效与治愈天数:治疗组57例显效,且治愈天数为4.7±1.4d,而对照组仅21例显效,且治愈天数为10.4±1.9d,两组相比均有显著性差异(P<0.01)。结论:妈咪爱联合思密达辅助治疗母乳性黄疸有明显效果,经济方便,无严重不良反应,值得推广。Objective： To observe the effect of Mami′ai combined with smecta in reducing serum bilirubin of breast milk jaundice patient and influence on the treatment course.Methods： A total of 198 patients with breast milk jaundice were randomly divided into treatment group and control group.The control group accepted routine therapy,whereas the treatment group was given Mami′ai and Smecta orally in addition to routine therapy.Results： The serum bilirubin of treatment group was 69.04±11.17 μmol·L-1 and control group was 92.10±14.76 μmol·L-1.There was a significant difference between two groups（P0.01）.57 cases of treatment group had marked effect and the cure duration was 4.7±1.4 d,on the other hand,21 cases of control group had marked effect and the cure duration was 10.4±1.9 d.There was a significant difference between two groups（P0.01）.Conclusion： Mami′ai combined with smecta has a significant effect on breast milk jaundice for adjuvant therapy.It is inexpensive and convenient without any side effects and worth to introduce.

关 键 词：妈咪爱 思密达 母乳性黄疸 疗效 

分 类 号：R722.1[医药卫生—儿科]